Skip to content

Comparision the effect of vaginal pomad of honey and clotrimazol on treatment of vaginal candidiasis in women referred to Hajar hospital gynecologic clinic in Shahrekord

Comparision the effect of vaginal pomad of honey and clotrimazol on treatment of vaginal candidiasis in women referred to Hajar hospital gynecologic clinic in Shahrekord

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013071013933N1
Enrollment
80
Registered
2013-07-14
Start date
2011-04-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Candidal vaginitis. Candidiasis of vulva and vagina (N77.1*)

Interventions

Intervention 1: Clotrimazol group: Patients in clotrimazol group used one applicator of 2% clotrimazol pomad every night for one week. Intervention 2: Honey group: Patients in honey group used one app
Treatment - Drugs
Clotrimazol group: Patients in clotrimazol group used one applicator of 2% clotrimazol pomad every night for one week.
Honey group: Patients in honey group used one applicator of 70% honey pomad every night for one week.

Sponsors

Vice chancellor for research and technology, Shahrekord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: presence of clinical symptoms of candidiasis; get married; tendency to participate in the study. Exclusion criteria:diabetes mellitus; immune deficiency; pregnancy; consumption of immunosuppressive drugs.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Vaginal discharge. Timepoint: At the first, three and seven days after beginning of treatment. Method of measurement: Self- making questionnaire.;Vaginal inflamation. Timepoint: At the first, three and seven days after beginning of treatment. Method of measurement: Self- making questionnaire.;Itching. Timepoint: At the first, three and seven days after beginning of treatment. Method of measurement: Visual Analoque Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShayeste Banaeian

Shahrekord University of Medical Sciences

shbanaeian@yahoo.com+98 38 1333 5652

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026